Yeleswaram Krishnaswamy's Form 4 filing
Rapport Therapeutics, Inc. (RAPP) · filed Apr 21, 2026
- Accession no.
- 0001193125-26-167091
- Filed
- Apr 21, 2026
- Trade date
- Apr 17, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $808.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yeleswaram KrishnaswamyCIK 0002022156 | Officer (Chief Development Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 17, 2026 | Common Stock | SSaleDisposed | −20,225 | $39.99 | −$808,797.75 | 246,426 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.